dipyridamole has been researched along with Erectile Dysfunction in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of 615 patients with impotence of varying etiologies who were followed from 12 to 96 months after the institution of intracavernous self-injection therapy with vasoactive drugs (papaverine alone, papaverine and alpha-blockers, and Ceritine, a new multilevel acting drug) 87% (533 patients) returned for followup visits or were regularly contacted." | 3.68 | Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. ( Floresco, J; Greco, E; Nollet, F; Shoukry, K; Virag, R, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sussman, H | 1 |
| Labastie, MN | 1 |
| Hauet, P | 1 |
| Allaire, E | 1 |
| Lombion, S | 1 |
| Virag, R | 2 |
| Shoukry, K | 1 |
| Floresco, J | 1 |
| Nollet, F | 1 |
| Greco, E | 1 |
| Doremieux, J | 1 |
| Reziciner, S | 1 |
| Grinenwald, P | 1 |
| Bondil, P | 1 |
3 other studies available for dipyridamole and Erectile Dysfunction
| Article | Year |
|---|---|
Ultrasonography after pharmacological stimulation of erection for the diagnosis and therapeutic follow-up of erectile dysfunction due to cavernovenous leakage.
Topics: Adult; Aged; Atropine; Blood Flow Velocity; Computed Tomography Angiography; Dipyridamole; Drug Comb | 2020 |
Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases.
Topics: Adrenergic alpha-Antagonists; Atropine; Consumer Behavior; Dipyridamole; Drug Combinations; Drug The | 1991 |
[Injections into the corpora cavernosa. The pros and cons].
Topics: Dipyridamole; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Patient Dropouts; Penis; P | 1987 |